⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
THE SKIN OF COLOR SOCIETY (SOCS) SUCCESSFULLY PRESENTS LANDMARK SYMPOSIUM CHAMPIONING EVIDENCE-BASED DERMATOLOGY AND COLLABORATION
prnewswire.com
ABBV
JNJ
ARQT
BMY
LLY
INCY
SNY
REGN
PFE
UCB
BIIB
ORGN
TAK
ELMD
Amphista Therapeutics presents the discovery, characterisation and chemical structure of AMX-883, an orally bioavailable, highly potent and selective DCAF16 degrader of BRD9 at AACR 2026
globenewswire.com
LLY
Rznomics Reports Interim Clinical Data for RZ-001 in Hepatocellular Carcinoma at AACR 2026 Demonstrating Encouraging Efficacy and Favorable Safety Profile
prnewswire.com
LLY
ISPE Announces 2026 Facility of the Year Awards (FOYA) Category Winners
prnewswire.com
AMGN
SNY
LLY
AZN
TAK
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
prnewswire.com
LLY
U.S. Chamber Discusses How Medical Breakthroughs Are Extending Lives and Strengthening the Economy with YourUpdateTV
globenewswire.com
MRK
PFE
JNJ
BMY
GILD
LLY
AMGN
REGN
ABBV
BIIB
China Diabetes Devices Market Forecast and Company Analysis Report 2026-2034 Featuring Roche, Abbott Laboratories, Novo Nordisk, BD, Medtronic, Eli Lilly, and Sanofi
globenewswire.com
ABT
NVO
BDX
MDT
LLY
SNY
Blacksmith Medicines Announces Presentation at AACR Annual Meeting 2026
prnewswire.com
BSM
LLY
ACHIEVE-4, the longest Phase 3 study of Lilly's Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health
prnewswire.com
LLY
ATUM Appoints Industry Veteran Gavin Barnard, Ph.D., as Chief Scientific Officer
prnewswire.com
LLY